Addressing the Role of PARP Inhibitors in Different Breast Cancer Settings
April 10th 2018Jennifer Litton, MD, associate professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses her opinion on the use of PARP inhibitors in the field of breast cancer.